We are live on
!
Find out more
AG
Artal Group Portfolio holdings
AUM
$931M
1-Year Est. Return
41.63%
This Fund
S&P 500
This Quarter
Est. Return
-5.28%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$2.16B
AUM Growth
-$686M
(-24%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
7.45%
Top 10 Holdings %
Top 10 Hldgs %
54.85%
Holding
104
New
19
Increased
23
Reduced
7
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$34.9M |
| 2 |
Bank of America
BAC
|
+$19.3M |
| 3 |
Citizens Financial Group
CFG
|
+$18.4M |
| 4 |
Amazon
AMZN
|
+$17.6M |
| 5 |
Mastercard
MA
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$27.5M |
| 2 |
Dollar General
DG
|
+$14.1M |
| 3 |
Occidental Petroleum
OXY
|
+$12.1M |
| 4 |
Aramark
ARMK
|
+$9.35M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$8.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.3% |
| 2 | Healthcare | 34.56% |
| 3 | Consumer Discretionary | 15.06% |
| 4 | Financials | 5.94% |
| 5 | Communication Services | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Lexicon Pharmaceuticals
LXRX
$890M
| $378M | 17.5% |
57,517,981
| – | – |
|
|
WW
2
DELISTED
WW International
WW
| $206M | 9.51% |
29,443,300
| – | – |
|
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$803B
| $103M | 4.77% |
500,000
-900,000
| -64% | -$186M |
|
4
CALL
Biogen
BIIB
$32.1B
| $99.2M | 4.59% |
235,000
+63,000
| +37% | +$24.8M |
|
5
CALL
Merck
MRK
$357B
| $97.7M | 4.52% |
1,781,600
-104,800
| -6% | -$5.93M |
|
|
6
CALL
Bank of America
BAC
$416B
| $77M | 3.56% |
5,000,000
+2,600,000
| +108% | +$41.8M |
|
7
BioMarin Pharmaceuticals
BMRN
$12.7B
| $59.8M | 2.77% |
480,000
| – | – |
|
8
CALL
MetLife
MET
$61.7B
| $55.6M | 2.57% |
1,234,200
+673,200
| +120% | +$30.3M |
|
9
CALL
Yum! Brands
YUM
$39.9B
| $55.1M | 2.55% |
973,700
| – | – |
|
10
CALL
JPMorgan Chase
JPM
$931B
| $54.5M | 2.52% |
900,000
| – | – |
|
|
11
Alphabet (Google) Class C
GOOG
$4.23T
| $49.3M | 2.28% |
1,804,942
+1,303,569
| +260% | +$34.9M |
|
12
Alnylam Pharmaceuticals
ALNY
$33.5B
| $49.1M | 2.27% |
470,000
+70,000
| +18% | +$7.09M |
|
13
Alibaba
BABA
$272B
| $47.9M | 2.21% |
575,000
+100,000
| +21% | +$9.02M |
|
14
Incyte
INCY
$24.8B
| $46.7M | 2.16% |
510,000
+100,000
| +24% | +$8.27M |
|
|
BLUE
15
DELISTED
bluebird bio
BLUE
| $42.3M | 1.95% |
27,020
+5,790
| +27% | +$7.64M |
|
16
CALL
McDonald's
MCD
$182B
| $39M | 1.8% |
400,000
-300,000
| -43% | -$28.5M |
|
17
CALL
Teva Pharmaceuticals
TEVA
$45.1B
| $37.4M | 1.73% |
600,000
+100,000
| +20% | +$5.81M |
|
|
CELG
18
CALL
DELISTED
Celgene Corp
CELG
| $34.6M | 1.6% |
+300,000
| New | +$35.8M |
|
|
19
Mastercard
MA
$499B
| $30.2M | 1.4% |
350,000
+175,000
| +100% | +$15.2M |
|
|
LNKD
20
DELISTED
LinkedIn Corporation
LNKD
| $27.5M | 1.27% |
110,000
+50,000
| +83% | +$12.4M |
|
|
ARRY
21
DELISTED
Array Biopharma Inc
ARRY
| $27.3M | 1.26% |
3,710,000
+710,000
| +24% | +$5.05M |
|
22
Ionis Pharmaceuticals
IONS
$8.55B
| $25.5M | 1.18% |
400,000
-5,000
| -1% | -$339K |
|
|
23
CALL
BioMarin Pharmaceuticals
BMRN
$12.7B
| $24.9M | 1.15% |
200,000
-100,000
| -33% | -$10.6M |
|
24
CALL
GE Aerospace
GE
$329B
| $24.8M | 1.15% |
208,662
| – | – |
|
25
CALL
Walmart Inc
WMT
$865B
| $24.7M | 1.14% |
+900,000
| New | +$25.5M |
|
Similar funds
BCM
ACM
SAM
NS
PA
ACM
CICI
CAM
Artal Group's Q1 2015 Portfolio in Review
As of Q1 2015, Artal Group held 104 positions worth $2.16B, down 24% from $2.85B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Artal Group deployed $161M of net new capital in Q1 2015, opening 19 new positions and adding to 23 existing holdings. Its largest new stake was Bank of America: 1,200,000 shares worth $18.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Aptiv, an estimated $1.88M trimmed.
- Artal Group's largest Q1 2015 buy was Bank of America: 1,200,000 shares worth $18.5M.
- Artal Group added most to Alphabet (Google) Class C in Q1 2015, an estimated $34.9M increase.
- Artal Group's biggest Q1 2015 reduction was Aptiv, cutting an estimated $1.88M.
- Artal Group fully exited PHARMACYCLICS INC in Q1 2015, selling an estimated $27.5M.
- Artal Group's ten largest holdings make up 55% of its $2.16B portfolio in Q1 2015.
- Artal Group opened 19 new positions and closed 33 in Q1 2015.
- Artal Group's portfolio value fell 24% quarter-over-quarter to $2.16B.
Based on Artal Group's 13F filing for Q1 2015, filed 13 May 2015.